Under construction – not a live service
Sign in
Taking people in ChinaNo phase

Looks back at internal radiation for gynecological cancers

Reviews past records of internal radiation treatment in women with gynecological cancers.

Plain-language title generated from the registry record
Registry title: Retrospective Study of Brachytherapy

Key facts

Where
Hangzhou, ChinaSee the site

AI summary: who the study is looking for

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

This study looks back at women who had brachytherapy for a gynecological cancer. The trial is looking for women aged 18 to 80.

Age
18 to 80 years
Sex
Women only
Disease stage
Gynecological cancer (the record gives no stage).
Earlier treatment
Must have had brachytherapy (internal radiation).

Main reasons for not taking part

  • Refusing to take part in the trial

Read by machine on 9 November 2026.

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 80 years old?

Source: NCT05242861, who can take part

Where in China

  • Zhejiang Cancer HospitalHangzhou, ChinaTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Trial details

Who runs it
Zhejiang Cancer Hospital
Trial code
NCT05242861
Record updated
16 February 2022
Original description
Brachytherapy for gynecological cancers will be studied retrospectively.Read full original descriptionShow less

A Retrospective Study of Brachytherapy in Gynecological Cancers

Brachytherapy for gynecological cancers will be studied retrospectively.

Inclusion: 18 - 80 female; Underwent brachytherapy; With gynecological cancer.

Exclusion: Refusal to enter this trial.

ClinicalTrials.gov NCT05242861